World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
26861
World Ranking
9435
National Ranking
4867

Overview

Judith E. Karp is affiliated with Johns Hopkins University in the United States and has contributed extensively to the field of medicine, with a particular focus on hematology. Their research spans several subfields including hematology, genetics, molecular biology, oncology, and public health, environmental and occupational health.

The researcher's primary areas of study include acute myeloid leukemia, myeloproliferative neoplasms, chronic myeloid leukemia treatments, histone deacetylase inhibitors, multiple myeloma, protein degradation, inhibitors, and ethics in clinical research.

Judith E. Karp's recent publications include:

  • Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse? (2020, Leukemia)
  • Advances in therapeutic options for newly diagnosed, high-risk AML patients (2021, Therapeutic Advances in Hematology)
  • Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome (2021, Bone Marrow Transplantation)
  • Hypoalbuminemia as a prognostic biomarker for higher mortality and treatment complications in acute myeloid leukemia (2021, Hematological Oncology)
  • The spectrum of genetic mutations in myelodysplastic syndrome: Should we update prognostication? (2021, eJHaem)

The scientist has frequently published in several venues, including:

  • Leukemia
  • Leukemia Research
  • UNC Libraries
  • Therapeutic Advances in Hematology
  • Bone Marrow Transplantation

Judith E. Karp has collaborated regularly with various co-authors, notably including Catherine Lai, Amy E. DeZern, Amanda L. Blackford, B. Douglas Smith, and Elihu H. Estey.

Best Publications

  • Increase in Candida krusei Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

    John R. Wingard;William G. Merz;Michael G. Rinaldi;Thomas R. Johnson

  • Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA

    Wenqiang Yu;David Gius;Patrick Onyango;Kristi Muldoon-Jacobs

  • Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.

    Joshua Wechsler;Marianne Greene;Michael A. McDevitt;John Anastasi

  • Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial.

    Judith E. Karp;Jeffrey E. Lancet;Scott H. Kaufmann;David W. End

  • Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms.

    Steven D. Gore;Stephen Baylin;Elizabeth Sugar;Hetty E. Carraway

  • Potential Role of Tamoxifen in Prevention of Breast Cancer

    Susan G. Nayfield;Judith E. Karp;Leslie G. Ford;F. Andrew Dorr

  • Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-Hydroperoxycyclophosphamide

    Andrew M. Yeager;Herbert Kaizer;George W. Santos;Rein Saral

  • Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients.

    J R Wingard;W G Merz;M G Rinaldi;C B Miller

  • Elevated Expression of the Apoptotic Regulator Mcl-1 at the Time of Leukemic Relapse

    Scott H. Kaufmann;Judith E. Karp;Phyllis A. Svingen;Stan Krajewski

  • From the Immunocompromised Host Society: The Design, Analysis, and Reporting of Clinical Trials on the Empirical Antibiotic Management of the Neutropenic Patient: Report of a Consensus Panel

    Philip A. Pizzo;Donald Armstrong;Gerald Bodey;Ben de Pauw

  • Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias

    Ivana Gojo;Anchalee Jiemjit;Jane B. Trepel;Alex Sparreboom

  • Expression of breast cancer resistance protein in blast cells from patients with acute leukemia

    Douglas D. Ross;Judith E. Karp;Tar T. Chen;L. Austin Doyle

  • Prevention and treatment of cancer-related infections

    Lindsey Robert Baden;William Bensinger;Michael Angarone;Corey Casper

  • Oral Norfloxacin for Prevention of Gram-Negative Bacterial Infections in Patients with Acute Leukemia and Granulocytopenia: A Randomized, Double-Blind, Placebo-Controlled Trial

    Judith E. Karp;William G. Merz;Carol Hendricksen;Barbara Laughon

  • SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes

    Francis J. Giles;Alison T. Stopeck;Lewis R. Silverman;Jeffrey E. Lancet

  • A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia.

    Jonathan M. Gerber;B. Douglas Smith;Brownhilda Ngwang;Hao Zhang

  • Phase I and pharmacodynamic study of taxol in refractory acute leukemias.

    Eric K. Rowinsky;Philip J. Burke;Judith E. Karp;Robert W. Tucker

  • Plasma inhibitory activity (PIA): a pharmacodynamic assay reveals insights into the basis for cytotoxic response to FLT3 inhibitors

    Mark Levis;Patrick Brown;B. Douglas Smith;Adam Stine

  • Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia

    Judith E. Karp;James D. Dick;Chris Angelopulos;Patricia Charache

  • Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem‐cell glycoprotein CD34 (My 10)

    Robert B. Geller;Marianna Zahurak;Craig A. Hurwitz;Philip J. Burke

Frequent Co-Authors

B. Douglas Smith
B. Douglas Smith Johns Hopkins University
Mark J. Levis
Mark J. Levis Johns Hopkins University
Michael A. McDevitt
Michael A. McDevitt Johns Hopkins University
John J. Wright
John J. Wright National Institutes of Health
James G. Herman
James G. Herman University of Pittsburgh
Richard J. Jones
Richard J. Jones Johns Hopkins University
Allan D. Hess
Allan D. Hess Johns Hopkins University
William G. Merz
William G. Merz Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online medical and healthcare degrees can offer greater flexibility and a more affordable way to start or advance your career in the medical field. Many students look for the phd in nursing online programs to pursue advanced research or leadership roles without stepping away from their current responsibilities.

If you’re already an RN, consider the most affordable accredited online rn to bsn programs to boost your qualifications and open up further career opportunities. For those with a non-nursing background, accelerated options such as direct entry msn programs for non nurses online provide a direct path into nursing with less time commitment.

Admission to medical and nursing schools in the US can be highly competitive, but there are accessible options out there. Researching the easiest nursing programs to get into might help you find a school that matches your academic profile and career goals.

Whether you choose to study online or on campus, these pathways allow you to begin or advance your healthcare career at your own pace while balancing your personal and professional life.

Best Scientists Citing Judith E. Karp

Trending Scientists